SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:47 pm Purchase |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
SUVRETTA CAPITAL MANAGEMENT LLC | 237,227 5.500% |
13,942 (+6.24%) |
Filing |
| 2021-10-15 4:49 pm Purchase |
2021-10-05 | 13G | Gemini Therapeutics, Inc. GMTX |
SUVRETTA CAPITAL MANAGEMENT LLC | 223,284 5.200% |
223,284 (New Position) |
Filing |